Medicamen Organics Limited (NSE:MEDIORG)

Medicamen Organics Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	394.3	381.88	252.72	221.47	209.75	250.47
Revenue Growth (YoY)	28.01%	51.11%	14.11%	5.59%	-16.26%	-20.45%
Cost of Revenue	244.72	247.85	157.99	157.97	156.6	158.61
Gross Profit	149.58	134.03	94.73	63.5	53.16	91.86
Selling, General & Admin	40.22	38.71	34.27	32.63	29.18	28.2
Other Operating Expenses	36.69	29.62	13.09	12.04	11.99	47.65
Operating Expenses	84.77	75.69	54.55	51.79	47.98	83.69
Operating Income	64.81	58.33	40.18	11.71	5.18	8.17
Interest Expense	-5.92	-4.8	-6.24	-5.66	-4.36	-4.43
Interest & Investment Income	0.95	0.95	0.13	0.08	0.23	0.12
Currency Exchange Gain (Loss)	0.16	0.16	0.02	-0.14	-0.01	-
Other Non Operating Income (Expenses)	-0.19	-0.34	-0.24	-0.47	-0.38	0.07
EBT Excluding Unusual Items	59.81	54.3	33.86	5.53	0.67	3.93
Other Unusual Items	0	0	10.51	8.07	1.88	-
Pretax Income	59.81	54.3	44.37	13.6	2.55	3.93
Income Tax Expense	14.06	13.83	18.13	3.9	1.54	1.49
Net Income	45.74	40.47	26.24	9.69	1.01	2.44
Net Income to Common	45.74	40.47	26.24	9.69	1.01	2.44
Net Income Growth	79.23%	54.22%	170.74%	855.92%	-58.46%	138.47%
Shares Outstanding (Basic)	12	11	8	6	6	6
Shares Outstanding (Diluted)	12	11	8	6	6	6
Shares Change (YoY)	28.87%	46.18%	26.05%	-	-	-
EPS (Basic)	3.88	3.67	3.47	1.62	0.17	0.41
EPS (Diluted)	3.84	3.66	3.47	1.62	0.17	0.41
EPS Growth	39.06%	5.48%	114.79%	855.92%	-58.46%	139.31%
Free Cash Flow	-25.97	-69.9	-40.13	-8.73	-5.79	-12.43
Free Cash Flow Per Share	-2.18	-6.32	-5.31	-1.46	-0.96	-2.07
Gross Margin	37.94%	35.10%	37.48%	28.67%	25.34%	36.68%
Operating Margin	16.44%	15.28%	15.90%	5.29%	2.47%	3.26%
Profit Margin	11.60%	10.60%	10.38%	4.38%	0.48%	0.97%
Free Cash Flow Margin	-6.59%	-18.30%	-15.88%	-3.94%	-2.76%	-4.96%
EBITDA	68.6	64.31	47.38	18.83	11.98	16.02
EBITDA Margin	17.40%	16.84%	18.75%	8.50%	5.71%	6.40%
D&A For EBITDA	3.79	5.97	7.19	7.12	6.8	7.84
EBIT	64.81	58.33	40.18	11.71	5.18	8.17
EBIT Margin	16.44%	15.28%	15.90%	5.29%	2.47%	3.26%
Effective Tax Rate	23.51%	25.47%	40.85%	28.71%	60.27%	37.91%
Revenue as Reported	395.4	382.83	252.9	229.62	211.87	250.66
Advertising Expenses	-	1.58	0.3	0.56	0.11	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.